Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient? Reply

Author(s):
Chinot, O.L.; Taphoorn, M.J.B.; Bais, C.; Bourgon, R.; Phillips, H.S.; Abrey, L.E.; Wick, W.; Mason, W.; Henriksson, R.; Saran, F.; Nishikawa, R.; Cloughesy, T.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-04-10
Language
English
Is part of
Journal of Clinical Oncology (2016), Vol. 34, no. 11, p. 1282-+
hdl
1887/114528
doi
10.1200/JCO.2015.65.2438